Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations
帕纳替尼 (AP24534) 抑制 MEKK3-KLF 信号传导并防止脑海绵状血管瘤的形成和进展
期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.aau0731
Jaesung P Choi, Rui Wang, Xi Yang, Xian Wang, Lu Wang, Ka Ka Ting, Matthew Foley, Victoria Cogger, Zhuo Yang, Feng Liu, Zhiming Han, Renjing Liu, Jonathan Baell, Xiangjian Zheng